TRAW icon

Traws Pharma
TRAW

Overview Fund Activity

20 hedge funds and large institutions have $4.29M invested in Traws Pharma in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 9 closing their positions.

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
6
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$3.35M
2
BlackRock
2
BlackRock
New York
$329K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$247K
4
HWA
4
Hillcrest Wealth Advisors
New Jersey
$96K
5
MA
5
MYDA Advisors
New York
$73K

Top Sellers

1
TCP
1
Tyndall Capital Partners
New York
$0
2
6CM
2
683 Capital Management
New York
$0
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
Wells Fargo
4
Wells Fargo
California
$0
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
WCG
27
Weaver Consulting Group
California
$0 284 – –
LTFS
28
Ladenburg Thalmann Financial Services
Florida
$0 67 – –
Barclays
29
Barclays
United Kingdom
$0 98 +90 +1,125%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 266 +266 New
1
2